» Articles » PMID: 16498049

Increased Serum Osteoprotegerin Values in Long-lived Subjects: Different Effects of Inflammation and Bone Metabolism

Overview
Specialty Endocrinology
Date 2006 Feb 25
PMID 16498049
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To evaluate serum osteoprotegerin (OPG) concentrations in relation to age-dependent changes in serum markers of bone metabolism and systemic inflammation.

Methods: Two-hundred and eighty-three healthy subjects were evaluated for plasma estimated creatinine clearance (Cr-clearance), C-reactive protein (CRP), bone alkaline phosphatase, C-telopeptides of type-1 collagen (CrossLaps), nuclear factor-kappaB ligand (RANKL) and OPG concentrations.

Results: In adult subjects (82 cases aged between 27 and 64 years) serum OPG concentrations were significantly and independently correlated with RANKL and Cr-clearance (R(2): 0.29), but not with CRP and biochemical markers of bone metabolism. In old subjects who were between 65 and 84 years of age (52 cases) serum OPG concentrations were significantly higher as compared with the adult subjects and correlated independently and significantly with serum RANKL, Cr-clearance and CrossLaps values (R(2): 0.63). The highest OPG values were found in the long-lived subjects (149 cases with ages between 85 and 110 years) who also showed increased serum CrossLaps and CRP concentrations as compared with the younger subjects. However, in the long-lived subjects serum OPG concentrations were significantly and independently correlated with Cr-clearance and CRP (R(2): 0.45) but not with CrossLaps values.

Conclusions: These data would suggest that different factors might be responsible for the age-dependent enhancement of OPG production. Bone metabolism would seem to be the most important factor influencing serum OPG concentrations in old subjects under 85 years of age, whereas in long-lived subjects the circulating values of this cytokine seem to be mainly correlated with serum CRP which could be a marker of inflammation and cardiovascular risk.

Citing Articles

Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study.

Bruno D, Fedele A, Tolusso B, Barini A, Petricca L, Di Mario C Front Med (Lausanne). 2021; 8:613889.

PMID: 33732715 PMC: 7959810. DOI: 10.3389/fmed.2021.613889.


Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults.

Coulson J, Bagley L, Barnouin Y, Bradburn S, Butler-Browne G, Gapeyeva H Osteoporos Int. 2017; 28(9):2683-2689.

PMID: 28585053 DOI: 10.1007/s00198-017-4104-2.


Cystatin C as a potential predictor of osteoprotegerin levels in healthy men, a cross-sectional, observational study.

Kulcsar-Jakab E, Petho Z, Pap Z, Kalina E, Foldesi R, Balogh A BMC Musculoskelet Disord. 2015; 16:227.

PMID: 26311162 PMC: 4551745. DOI: 10.1186/s12891-015-0684-1.


Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss.

Trouvin A, Goeb V Clin Interv Aging. 2011; 5:345-54.

PMID: 21228900 PMC: 3010170. DOI: 10.2147/CIA.S10153.


Involvement of molecular mimicry between human T-cell leukemia virus type 1 gp46 and osteoprotegerin in induction of hypercalcemia.

Sagara Y, Inoue Y, Sagara Y, Kashiwagi S Cancer Sci. 2009; 100(3):490-6.

PMID: 19134004 PMC: 11159199. DOI: 10.1111/j.1349-7006.2008.01061.x.